Biocon shares surge 7.79% on approval of Ustekinumab biosimilar in Japan 0 07.01.2025 10:08 Thehindubusinessline.com The approval follows a successful partnership with Yoshindo Inc., which will handle commercialisation and marketing in Japan Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
